275 related articles for article (PubMed ID: 34685635)
1. Regulation of T Cells in Cancer by Nitric Oxide.
Navasardyan I; Bonavida B
Cells; 2021 Oct; 10(10):. PubMed ID: 34685635
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration.
Xu J; Luo Y; Yuan C; Han L; Wu Q; Xu L; Gao Y; Sun Y; Ma S; Tang G; Li S; Sun W; Gong Y; Xie C
Int J Biol Sci; 2020; 16(9):1563-1574. PubMed ID: 32226302
[TBL] [Abstract][Full Text] [Related]
3. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.
Raber PL; Thevenot P; Sierra R; Wyczechowska D; Halle D; Ramirez ME; Ochoa AC; Fletcher M; Velasco C; Wilk A; Reiss K; Rodriguez PC
Int J Cancer; 2014 Jun; 134(12):2853-64. PubMed ID: 24259296
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8
Cartwright ANR; Suo S; Badrinath S; Kumar S; Melms J; Luoma A; Bagati A; Saadatpour A; Izar B; Yuan GC; Wucherpfennig KW
Cancer Immunol Res; 2021 Apr; 9(4):470-485. PubMed ID: 33514509
[TBL] [Abstract][Full Text] [Related]
6. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma.
Karpuzoglu E; Fenaux JB; Phillips RA; Lengi AJ; Elvinger F; Ansar Ahmed S
Endocrinology; 2006 Feb; 147(2):662-71. PubMed ID: 16293660
[TBL] [Abstract][Full Text] [Related]
7. Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
Langle YV; Balarino NP; Belgorosky D; Cresta Morgado PD; Sandes EO; Marino L; Bilbao ER; Zambrano M; Lodillinsky C; Eiján AM
Nitric Oxide; 2020 May; 98():50-59. PubMed ID: 32147582
[TBL] [Abstract][Full Text] [Related]
8. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
9. A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.
Li M; Xing S; Zhang H; Shang S; Li X; Ren B; Li G; Chang X; Li Y; Li W
Oncol Rep; 2016 Mar; 35(3):1329-39. PubMed ID: 26752000
[TBL] [Abstract][Full Text] [Related]
10. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
[TBL] [Abstract][Full Text] [Related]
11. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
[TBL] [Abstract][Full Text] [Related]
12. Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells.
Schouppe E; Van Overmeire E; Laoui D; Keirsse J; Van Ginderachter JA
Immunobiology; 2013 Nov; 218(11):1385-91. PubMed ID: 23932436
[TBL] [Abstract][Full Text] [Related]
13. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.
Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q
Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167
[TBL] [Abstract][Full Text] [Related]
14. SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.
Redd PS; Ibrahim ML; Klement JD; Sharman SK; Paschall AV; Yang D; Nayak-Kapoor A; Liu K
Cancer Res; 2017 Jun; 77(11):2834-2843. PubMed ID: 28381543
[TBL] [Abstract][Full Text] [Related]
15. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
Kusmartsev SA; Li Y; Chen SH
J Immunol; 2000 Jul; 165(2):779-85. PubMed ID: 10878351
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells.
Shime H; Maruyama A; Yoshida S; Takeda Y; Matsumoto M; Seya T
Oncoimmunology; 2017; 7(1):e1373231. PubMed ID: 29296526
[TBL] [Abstract][Full Text] [Related]
17. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL
Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191
[TBL] [Abstract][Full Text] [Related]
18. Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells.
Liversidge J; Grabowski P; Ralston S; Benjamin N; Forrester JV
Immunology; 1994 Nov; 83(3):404-9. PubMed ID: 7530691
[TBL] [Abstract][Full Text] [Related]
19. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.
Lu L; Bonham CA; Chambers FG; Watkins SC; Hoffman RA; Simmons RL; Thomson AW
J Immunol; 1996 Oct; 157(8):3577-86. PubMed ID: 8871658
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase in T cells regulates T cell death and immune memory.
Vig M; Srivastava S; Kandpal U; Sade H; Lewis V; Sarin A; George A; Bal V; Durdik JM; Rath S
J Clin Invest; 2004 Jun; 113(12):1734-42. PubMed ID: 15199408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
